Teachers Retirement System of The State of Kentucky Boosts Stock Holdings in Syneos Health, Inc. (NASDAQ:SYNH)

Teachers Retirement System of The State of Kentucky lifted its stake in shares of Syneos Health, Inc. (NASDAQ:SYNHGet Rating) by 1.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 66,889 shares of the company’s stock after acquiring an additional 1,100 shares during the quarter. Teachers Retirement System of The State of Kentucky owned 0.07% of Syneos Health worth $5,414,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of SYNH. BlackRock Inc. increased its position in shares of Syneos Health by 16.3% during the first quarter. BlackRock Inc. now owns 11,527,780 shares of the company’s stock worth $933,174,000 after acquiring an additional 1,617,330 shares during the period. Silvercrest Asset Management Group LLC increased its position in shares of Syneos Health by 490.6% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 1,427,767 shares of the company’s stock worth $145,924,000 after acquiring an additional 1,186,001 shares during the period. Alliancebernstein L.P. increased its position in shares of Syneos Health by 576.4% during the fourth quarter. Alliancebernstein L.P. now owns 1,343,624 shares of the company’s stock worth $137,963,000 after acquiring an additional 1,144,983 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Syneos Health by 33.7% during the first quarter. Massachusetts Financial Services Co. MA now owns 2,868,800 shares of the company’s stock worth $232,229,000 after acquiring an additional 723,812 shares during the period. Finally, Cooke & Bieler LP increased its holdings in Syneos Health by 39.1% in the first quarter. Cooke & Bieler LP now owns 2,359,503 shares of the company’s stock valued at $191,002,000 after buying an additional 663,152 shares during the last quarter. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Syneos Health Stock Performance

NASDAQ SYNH opened at $51.51 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.10 and a quick ratio of 1.10. Syneos Health, Inc. has a 1 year low of $50.74 and a 1 year high of $104.18. The company has a market capitalization of $5.29 billion, a PE ratio of 19.36 and a beta of 1.74. The company has a fifty day moving average of $66.90 and a two-hundred day moving average of $71.82.

Syneos Health (NASDAQ:SYNHGet Rating) last announced its earnings results on Tuesday, August 2nd. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.05. Syneos Health had a net margin of 5.13% and a return on equity of 14.04%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter in the prior year, the firm earned $0.86 earnings per share. The business’s quarterly revenue was up 6.0% compared to the same quarter last year. As a group, analysts expect that Syneos Health, Inc. will post 4.54 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Evercore ISI dropped their target price on Syneos Health to $73.00 in a report on Tuesday, August 9th. Guggenheim lowered Syneos Health from a “buy” rating to a “neutral” rating in a report on Wednesday. William Blair lowered Syneos Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 3rd. Citigroup dropped their target price on Syneos Health from $80.00 to $70.00 in a report on Wednesday, August 3rd. Finally, UBS Group started coverage on Syneos Health in a report on Wednesday, September 7th. They issued a “neutral” rating and a $68.00 target price on the stock. Six analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $81.10.

Insider Transactions at Syneos Health

In other news, CAO Donna Hildebrand Kralowetz sold 1,149 shares of the stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $73.16, for a total transaction of $84,060.84. Following the completion of the sale, the chief accounting officer now owns 6,805 shares in the company, valued at $497,853.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, CAO Donna Hildebrand Kralowetz sold 1,149 shares of the firm’s stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $73.16, for a total value of $84,060.84. Following the completion of the sale, the chief accounting officer now owns 6,805 shares in the company, valued at $497,853.80. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Michael Lee Brooks sold 1,002 shares of the firm’s stock in a transaction dated Tuesday, July 19th. The shares were sold at an average price of $74.00, for a total transaction of $74,148.00. Following the completion of the sale, the chief operating officer now owns 49,556 shares of the company’s stock, valued at approximately $3,667,144. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,203 shares of company stock worth $1,631,443. Company insiders own 0.34% of the company’s stock.

Syneos Health Company Profile

(Get Rating)

Syneos Health, Inc provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development.

Recommended Stories

Want to see what other hedge funds are holding SYNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syneos Health, Inc. (NASDAQ:SYNHGet Rating).

Institutional Ownership by Quarter for Syneos Health (NASDAQ:SYNH)

Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.